Abstract: The invention relates to a method for producing free powder particles of polyamide, impregnated with at least one cosmetic or pharmaceutical agent. The present invention also relates to free powder particles of polyamide having a content of at least 25% by weight of a cosmetic or pharmaceutical agent other than water, to the use of said particles in a cosmetic, pharmaceutical or perfumery products, and to compositions containing such particles.
Abstract: Disclosed herein is a composition for oral administration of O-desmethyltramadol that is effective for overcoming resistance to tramadol in patients.
Abstract: There is disclosed a method for treating disorders modulated by at least opiate receptor activity or monoamine activity, including acute and chronic pain, comprising administering a pharmaceutical formulation comprising O-desmethyltramadol. Methods are also provided that are effective for overcoming resistance to tramadol in patients.
Abstract: A glassy extrusion encapsulation composition and a method of making the composition are provided. The encapsulation composition comprises an encapsulate encapsulated in a glassy matrix comprising 0.5 to 12% by weight, based on the total weight of the glassy matrix, of at least one surface active plant extract, and 88 to 99.5% of at least one carbohydrate. The addition of a surface active plant extract to a carbohydrate matrix markedly increases the load of an encapsulate in the encapsulation composition. Such glassy matrices are useful for encapsulation of encapsulates, for example, flavors and medications. A food composition containing the encapsulation composition is also provided.
Type:
Grant
Filed:
March 14, 2013
Date of Patent:
June 27, 2017
Assignee:
McCormick & Company, Incorporated
Inventors:
Dmitriy Zasypkin, Shriram Paranjpe, Michael Reick, Suzanne Johnson
Abstract: A cosmetic composition containing in a cosmetically acceptable aqueous medium: one or more non-silicone fatty substances, one or more surfactants, one or more vinylformamide/vinylamine copolymers, and one or more silicones. Can be used for the styling of the hair and can make possible to obtain a lasting hold of the hairstyle and also hair conditioning properties.
Type:
Grant
Filed:
January 30, 2009
Date of Patent:
April 4, 2017
Assignee:
L'OREAL
Inventors:
Katarina Benabdillah, Estelle Mathonneau
Abstract: A micro encapsulation material for use with storage unstable, therapeutic and nutritional agents which release the therapeutic and nutritional agents in predetermined locations in the gastro intestinal tract in which the microencapsulation material is formed by combining a food grade treated carbohydrate with a water soluble food grade protein. The therapeutic and nutritional agents form an oil phase which is emulsified with the water dispersed or dissolved encapsulant to encapsulate the therapeutic and nutritional agents. These agents may be oils or oil soluble or oil dispersible. The agents that may be encapsulated include lipids (oils including oxygen sensitive oils, fatty acids, triglycerides) and oil soluble and oil dispersible ingredients (including pharmaceuticals, probiotics, protein therapeutics and bioactives). The protein used may include any film forming water soluble protein or hydrolyzed protein and includes milk proteins such as casein and its derivatives or whey proteins.
Type:
Grant
Filed:
November 22, 2004
Date of Patent:
March 14, 2017
Assignee:
COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
Inventors:
Richard Head, Luz Sanguansri, Mary Ann Augustin
Abstract: Provided is an oral solid preparation of a compound anti-tubercular drug, wherein the active ingredients are rifampicin, isoniazid, pyrazinamide and ethambutol hydrochloride. The compound oral solid preparation is a coated tablet with coated core or a coated three-layer tablet, wherein the two active ingredients rifampicin and isoniazid do not come to contact with each other directly. The compound oral solid preparation not only improves the stability of the compound preparation, but also improves the bioavailability of rifampicin.
Type:
Grant
Filed:
April 10, 2012
Date of Patent:
January 31, 2017
Assignee:
Zhejiang Hisun Pharmaceutical Co., Ltd.
Inventors:
Maojian Gu, Qilan Zheng, Chao Xu, Ning Li, Guixian Chen, Lan Zheng, Min Wang, Lintao Jiang
Abstract: The present invention relates to a composition comprising, or consisting of 2-50 mg/ml hyaluronic acid, 0.1-500 mg/ml of biodegradable particles with an average mean particle diameter of 1 nm-500 ?m, 1 pg/ml-10 ?g/ml cytokines, where the concentrations specified are based in each case on the total volume (w/v) of the composition and where the cytokines are enclosed in the biodegradable particles, and to their use in the treatment of cartilage defects, for example traumatic cartilage defects or osteoarthrosis.
Type:
Grant
Filed:
November 30, 2011
Date of Patent:
January 10, 2017
Assignee:
CHARITE—UNIVERSITATSMEDIZIN BERLIN
Inventors:
Kristin Andreas, Jochen Ringe, Michael Sittinger
Abstract: Provided are methods of treating pain, including neuropathic pain, in human and veterinary individuals. These methods employ locally administrable pharmaceutical gallium compositions, including pharmaceutical gallium compositions suitable for administration to the skin and mucous membranes. The compositions comprise pharmaceutically acceptable gallium compounds, such as gallium maltolate or gallium nitrate, together with pharmaceutically acceptable carriers suitable for local administration, including those suitable for topical administration. The administration of such compositions provides relief from pain, itching, allodynia, hyperalgesia, and related symptoms.
Abstract: A water-in-oil type sunscreening cosmetic material containing phenylbenzimidazole sulfonic acid, 2-amino-2-methyl-1,3-propanediol and/or 2-amino-2-(hydroxymethyl)propane-1,3-diol, and octyl methoxycinnamate.
Abstract: Provided is an aqueous manicure composition by which three-dimensional patterns and shapes can freely be formed in an one-liquid, wherein the shapes are maintained after drying, and make-up such as a nail art can easily be enjoyed. The above aqueous manicure composition is characterized by containing at least an acrylic resin emulsion, a thickener and an extender.
Abstract: The present invention provides a pharmaceutical composition for the treatment and prophylaxis of angina and myocardial infarction, wherein a combination of a tea extract (catechins) and an antianginal drug are proved therapeutically potent in treating angina and mycocardial infarction induced from myocardial ischemia. The present invention also provides a use of a tea extract (catechins) in treating and preventing angina.
Abstract: The invention concerns a composition and method for treating an ungual infection, the composition comprising an iodophor and dimethylsulfoxide (DMSO).
Abstract: The invention provides methods and compositions for wound treatment and/or blood clot formation, e.g., arresting the flow of blood from an open wound. The methods and compositions provide for promoting and accelerating wound healing and optionally provide for inhibition of microbial infection and/or a local analgesic effect.
Abstract: A water-in-silicone oil (W/S) macroemulsion cosmetic composition of waterdrop quick break type is provided. The silicone oil phase part (S) contains a partly crosslinked emulsifiable silicone elastomer, a partly crosslinked non-emulsifiable silicone elastomer, and silicone oil, and the aqueous phase part (W) contains 1,3-butylene glycol and a lower alcohol, and also, at least one member selected from the group consisting of organic acid salts, inorganic salts, and polyhydric alcohols excluding glycerin and 1,3-butylene glycol as a freeze stabilizer at a predetermined composition. The cosmetic composition instantaneously releases water upon application on the skin. The cosmetic composition is stable at the extremely low temperature of ?20° C., and it retains its dispersion stability even after repeated freezing and thawing, and accordingly, it can be used in a variety of cosmetic product.
Abstract: The present invention can retain the volume of a tablet large without increasing the thickness of the tablet or the like dimension and prevents a plurality of tablets from sticking to each other even if they are subjected to a film-coating or the like treatment, so as to improve the yield. The tablet is a tablet (1) longer in one direction when seen in plan. The tablet (1) has side edges (6) each of which extends in a longitudinal direction and is formed in the shape of a curve projecting outwardly in plan view. The curve has a radius of curvature (R1) set to at least 1.5 times a length (L) of the tablet. This makes a projected area of the tablet (1) in plan view at least 97% with respect to a projected area of a standard elliptical tablet having opposite end portions each of which is formed by a semi-circle having a diameter of a width (W) of the tablet.
Abstract: The present invention generally relates to a method of making nanoparticles and uses thereof. In particular, the invention relates to methods of making metal nanoparticles (MNPs). The invention also relates to antimicrobial uses of the nanoparticles.
Type:
Grant
Filed:
July 9, 2013
Date of Patent:
April 19, 2016
Assignee:
RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK
Inventors:
George John, Praveen Kumar Vemula, Pulickel Ajayan, Ashavani Kumar
Abstract: A cosmetic and a topical skin preparation comprising a higher alcohol-modified silicone (A) with the following general formula (1) wherein R1 is, e.g., an alkyl group; P is a monovalent organic group that contains the Si—O bond or is a long-chain monovalent hydrocarbyl group; at least one Q is a higher alcohol modifying group (—(C10-C30)-OH); and (m1+m2+m3) is a number in the range from 0 to 55 and most favorably (m1+m2+m3) is 1.
Abstract: The present disclosure describes compositions operable for releasing nitric oxide under photochemical conditions. The compositions include a titanium dioxide nanomaterial and a nitric oxide-releasing compound deposited on the titanium dioxide nanomaterial that is operable to release nitric oxide under photochemical conditions. Titanium dioxide nanomaterials include, for example, titanium dioxide nanotubes. To facilitate the photochemical release of nitric oxide, some embodiments of the compositions further include a semiconductor that is deposited on the titanium dioxide nanotubes. Both the semiconductor and the nitric oxide-releasing compound may be deposited on the interior surface, exterior surface, or both of the titanium dioxide nanotubes. A polymer may wrap the titanium dioxide nanotubes to protect the nitric oxide-releasing compounds from moisture. Also disclosed herein are methods for producing such compositions and medical devices obtained therefrom.
Type:
Grant
Filed:
March 30, 2010
Date of Patent:
March 8, 2016
Assignee:
THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Inventors:
Kenneth J. Balkus, Jr., Chalita Ratanatawanate